A Phase IIb controlled, randomized, study of Allocetra in sepsis patients
Latest Information Update: 03 Mar 2021
At a glance
- Drugs Leukocyte-cell-therapy-Enlivex-Therapeutics (Primary)
- Indications Multiple organ failure
- Focus Therapeutic Use
- Sponsors Enlivex Therapeutics
- 03 Mar 2021 New trial record
- 01 Mar 2021 According to an Enlivex Therapeutics media release, the company plans to initiate this trial in the first quarter of 2021.